artesunic acid has been researched along with Escherichia coli Infections in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Li, J; Liu, M; Tian, W; Wei, S; Yang, Y; Yin, S | 1 |
Cao, H; Ding, G; Dong, Y; He, S; Jiang, W; Li, B; Li, J; Lu, Y; Luo, P; Zhang, L; Zhang, R; Zheng, J; Zhou, H | 1 |
2 other study(ies) available for artesunic acid and Escherichia coli Infections
Article | Year |
---|---|
Synergistic Activity of Fluoroquinolones Combining with Artesunate Against Multidrug-Resistant
Topics: Animals; Anti-Bacterial Agents; Artesunate; Drug Resistance, Multiple, Bacterial; Drug Synergism; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Fluoroquinolones; Microbial Sensitivity Tests | 2020 |
Antimalarial artesunate protects sepsis model mice against heat-killed Escherichia coli challenge by decreasing TLR4, TLR9 mRNA expressions and transcription factor NF-kappa B activation.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Bacteremia; Cells, Cultured; Endotoxins; Escherichia coli Infections; Female; Interleukin-6; Male; Mice; NF-kappa B; Oligodeoxyribonucleotides; RNA, Messenger; Sesquiterpenes; Toll-Like Receptor 4; Toll-Like Receptor 9; Tumor Necrosis Factor-alpha | 2008 |